Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers

BACKGROUND: Luminal A breast cancer defined as hormone receptor positive and human epidermal growth factor receptor 2 (HER2) negative is known to be heterogeneous. Previous study showed that luminal A tumours with the expression of basal markers ((cytokeratin (CK) 5 or CK5/6) or epidermal growth fac...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Cancer
Autors principals: Sung, Hyuna, Garcia-Closas, Montserrat, Chang-Claude, Jenny, Blows, Fiona M, Ali, H Raza, Figueroa, Jonine, Nevanlinna, Heli, Fagerholm, Rainer, Heikkilä, Päivi, Blomqvist, Carl, Giles, Graham G, Milne, Roger L, Southey, Melissa C, McLean, Catriona, Mannermaa, Arto, Kosma, Veli-Matti, Kataja, Vesa, Sironen, Reijo, Couch, Fergus J, Olson, Janet E, Hallberg, Emily, Olswold, Curtis, Cox, Angela, Cross, Simon S, Kraft, Peter, Tamimi, Rulla M, Eliassen, A Heather, Schmidt, Marjanka K, Bolla, Manjeet K, Wang, Qin, Easton, Douglas, Howat, William J, Coulson, Penny, Pharoah, Paul DP, Sherman, Mark E, Yang, Xiaohong R
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2016
Matèries:
Molecular Diagnostics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4742579/
https://ncbi.nlm.nih.gov/pubmed/26679376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.437
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars